Air India removes two pilots from duty after non-negative drug-test results
Two Air India pilots were taken off flying duties after non-negative initial drug-test results, pending confirmation. The carrier has screened nearly 400 cockpit crew under a one-time mandatory psychoactive-substance testing programme covering more than 5,000 pilots across Air India and Air India Express.
What happened
Two Air India pilots returned non-negative initial drug-test results and were removed from flying duties pending confirmation. The airline has screened nearly
Key facts
- 2 pilots
- Nearly 400 pilots screened
- More than 5,000 pilots across Air India and Air India Express
Why this matters
Any partnership or transaction diligence involving Air India should assess substance-testing controls, regulatory compliance processes and the resilience of cockpit staffing during enhanced screening.
What to watch
- Number and percentage of confirmatory positive results among screened cockpit crew.
- Reports of flight delays, cancellations or crew-shortage-driven schedule changes.
- DGCA commentary, audits, directives or industry-wide testing requirements.
- Whether screening is extended to cabin crew, maintenance personnel or other safety-sensitive roles.
- Customer-sentiment shifts, especially among corporate and premium travelers, following any confirmed cases.
- Air India disclosures on testing policy, employee assistance programmes or disciplinary standards.
- Complete confirmatory testing and determine whether the two crew members return to duty or face disciplinary action.
- Expand screening across the remaining Air India and Air India Express pilot population, likely with tighter documentation and confidentiality controls.
- Rebalance crew rosters, reserve capacity and flight schedules if additional personnel are temporarily removed from operations.
- Issue safety-focused communications to employees, regulators and customers emphasizing that non-negative initial tests are not final findings.
- Review whether the one-time programme transitions into periodic or random psychoactive-substance testing.